Preclinical News and Research

RSS

Study identifies a novel role for regulatory protein Bach1 in Parkinson's disease

Parkinson's disease (PD) is the most common neurodegenerative movement disorder, afflicting more than 10 million people worldwide and more than one million Americans. While there is no cure for PD, current therapies focus on treating motor symptoms and fail to reverse, or even address, the underlying neurological damage.

26 Oct 2021

'Switching on' Sight using Gene Therapy

AZoLifeSciences speaks to Dr. Raymond Wong about his latest research into eye health and we could potentially 'switch on' sight using gene therapy.

20 Oct 2021

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

Multi-institutional researchers have succeeded in efficiently delivering an immune checkpoint inhibitor (ICI) into the mouse brain, confirming its high efficacy and specificity in treating orthotopically transplanted mice with glioblastoma (GBM). The research was published in Nature Biomedical Engineering.

12 Oct 2021

Common drug to treat cancer reverses Alzheimer’s symptoms in mice

A drug commonly used to treat cancer can restore memory and cognitive function in mice that display symptoms of Alzheimer's disease, new UBC research has found.

6 Oct 2021

Novel Assay Platform for 3D Microfluidic Cancer Research

AMSBIO have supplied custom Chimeric antigen receptor (CAR)-T products to the University of Strathclyde (UoS) in Glasgow, UK, and ScreenIn3D Ltd, allowing them to perform novel immune-oncology assays in 3D microfluidic cancer models.

From AMS Biotechnology 1 Oct 2021

Study pinpoints means to restore the efficacy of drugs for acute myeloid leukemia

Researchers elucidate why certain drugs, in clinical trials, for treating a kind of acute myeloid leukemia often fail and revealed a means to restore their efficacy.

1 Oct 2021

Intermittent fasting slows aging and increases longevity in fruit flies, study shows

Whether intermittent fasting is called the 5:2 diet or the 16/8 method, celebrities swear that these eating regimens are a great way to lose weight. Fasting is now trendy, but real science backs up claims that fasting two days a week or restricting eating to an eight-hour window each day leads to weight loss.

30 Sep 2021

Novel process enables 3D imaging of human organs with micrometer resolution

Scientists recently demonstrated a process by which specific cell types in human organs can be investigated with micrometer precision.

15 Sep 2021

Pairing microscopy with AI to develop a rapid, accurate COVID-19 test

Beckman researchers paired microscopy with artificial intelligence to develop a COVID-19 test that's fast, accurate, and cost-effective. All we need to do is say "ahh."

13 Sep 2021

Family of naturally occurring proteins shows promise for treating ischemic stroke

Boosting a family of naturally occurring proteins that dampens inflammation in the body has been shown to be effective in reducing damage from an ischemic stroke, according to preclinical researchers at The University of Texas Health Science Center at Houston.

2 Sep 2021

Researchers pinpoint a lack of best practices in mammalian cell culture

A group of KAUST researchers and co-workers in Saudi Arabia and the United States examined 810 randomly selected papers on mammalian cell lines.

16 Aug 2021

Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester

Medicines Discovery Catapult (MDC) today announces the relaunch of radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) in Manchester.

5 Aug 2021

New formulation to administer antibodies for choroidal neovascularization therapy

Scientists have created a new formulation based on regulatory T-cell exosomes (rEXS) to administer vascular endothelial growth factor (VEGF) antibodies.

28 Jul 2021

Modification in some RNA molecules could protect against non-alcoholic fatty liver

RNA molecules while carrying genetic instructions from DNA to the protein-making machinery of cells could help guard against non-alcoholic fatty liver.

21 Jul 2021

Researchers use body-on-a-chip cancer models to study personalized immunotherapy response

Wake Forest researchers and clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer, one of the rarest cancers affecting only 1 in 100,000 people.

20 Jul 2021

Genetically engineering NK cells can target and kill glioblastoma stem cells

Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG-β signaling protein, which blocks NK cell activity.

18 Jun 2021

Preclinical News and Research

Study identifies a novel role for regulatory protein Bach1 in Parkinson's disease

'Switching on' Sight using Gene Therapy

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

Common drug to treat cancer reverses Alzheimer’s symptoms in mice

Novel Assay Platform for 3D Microfluidic Cancer Research

Study pinpoints means to restore the efficacy of drugs for acute myeloid leukemia

Intermittent fasting slows aging and increases longevity in fruit flies, study shows

Novel process enables 3D imaging of human organs with micrometer resolution

Pairing microscopy with AI to develop a rapid, accurate COVID-19 test

Family of naturally occurring proteins shows promise for treating ischemic stroke

Researchers pinpoint a lack of best practices in mammalian cell culture

Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester

New formulation to administer antibodies for choroidal neovascularization therapy

Modification in some RNA molecules could protect against non-alcoholic fatty liver

Researchers use body-on-a-chip cancer models to study personalized immunotherapy response

Genetically engineering NK cells can target and kill glioblastoma stem cells

Novel platform may lead to more improved gene therapies

Commonly used antidepressant drugs can also help the immune system to attack cancer

Gene therapy may be a safe and effective single-dose treatment for hypophosphatasia

Study discovers novel function for metabolic enzyme medium-chain acyl-CoA dehydrogenase

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics